Literature DB >> 6154112

Neutrophils in antiviral immunity: inhibition of virus replication by a mediator produced by bovine neutrophils.

B T Rouse, L A Babiuk, P M Henson.   

Abstract

Neutrophils collected from bovine mammary glands were placed in culture with virus-infected cell preparations that had been inactivated by ultraviolet light. Upon culture with infectious bovine rhinotracheitis (IBR) virus-infected Georgia bovine kidney cells, a material was released from the neutrophils that, like interferon, inhibited the replication of vesicular stomatitis virus and IBR virus. Cell-free IBR virus was a less effective inducer of the inhibitor produced by neutrophils. Other herpesviruses (including herpes simplex type 1), as well as equine rhinopneumonitis virus and pseudorabies virus, caused release of the inhibitor, but most other viruses tested, including Newcastle disease virus, a good inducer of type 1 interferon, failed to stimulate the production of inhibitor by polymorphonuclear neutrophils. Preliminary characterization studies revealed differences between the inhibitor produced by the polymorphonuclear neutrophils and type 1 and type II bovine interferons. The possible role of such an inhibitor in the recovery from herpesvirus infection is briefly discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6154112     DOI: 10.1093/infdis/141.2.223

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Comparison of cytotoxic properties of neonatal and adult neutrophils and monocytes and enhancement by cytokines.

Authors:  E R Stiehm; R L Roberts; B J Ank; S Plaeger-Marshall; N Salman; L Shen; M W Fanger
Journal:  Clin Diagn Lab Immunol       Date:  1994-05

2.  Selective inhibition of human neutrophil chemotaxis by ECHO-virus, type 9.

Authors:  B Bültmann; H J Eggers; O Haferkamp
Journal:  Klin Wochenschr       Date:  1981-06-01

3.  Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice.

Authors:  Terrence M Tumpey; Adolfo García-Sastre; Jeffery K Taubenberger; Peter Palese; David E Swayne; Mary J Pantin-Jackwood; Stacey Schultz-Cherry; Alicia Solórzano; Nico Van Rooijen; Jacqueline M Katz; Christopher F Basler
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Direct inactivation of viruses by human granulocyte defensins.

Authors:  K A Daher; M E Selsted; R I Lehrer
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

5.  Direct inactivation of viruses by MCP-1 and MCP-2, natural peptide antibiotics from rabbit leukocytes.

Authors:  R I Lehrer; K Daher; T Ganz; M E Selsted
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

6.  A neutrophil-derived antiviral protein: induction requirements and biological properties.

Authors:  H B Ohmann; M Campos; D R Fitzpatrick; N Rapin; L A Babiuk
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

7.  Phagocytosis of herpes simplex virus by human granulocytes and monocytes.

Authors:  J A Van Strijp; K P Van Kessel; M E van der Tol; A C Fluit; H Snippe; J Verhoef
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

8.  (2'-5') Oligo A synthetase in human polymorphonuclear cells increased activity in interferon treatment and in viral infections.

Authors:  A Schattner; G Merlin; V Bregman; T Hahn; S Levin; M Revel; D Wallach
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

9.  Role for macrophage inflammatory protein 2 (MIP-2), MIP-1alpha, and interleukin-1alpha in the delayed-type hypersensitivity response to viral antigen.

Authors:  Terrence M Tumpey; Robin Fenton; Sara Molesworth-Kenyon; John E Oakes; Robert N Lausch
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea.

Authors:  T M Tumpey; S H Chen; J E Oakes; R N Lausch
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.